By Cyber-Duck, Posted 11 years ago
Syntaxin are leaders within the biotechnology industry with their innovative approach to developing novel drugs to tackle unmet clinical needs. Syntaxin's product pipeline surrounds the development of biopharmaceutical products for the treatment of diseases such as respiratory diseases, metabolic disorders, nerve and chronic pain disorders and endocrine related tumours.
Syntaxin's old image was not representative of the brand anymore. Syntaxin required a rebrand to illustrate their dynamic and innovative approach to creating medicines. Their Website was out of date and main target audience groups were not finding the information they required.
Cyber-Duck rebranded Syntaxin as a cutting edge and slick biopharmaceutical firm. The new website better represents Syntaxin's innovative approach and status as a growing company within the bio-tech sector. Not only does the new website have an aesthetical feel which is friendly on the eye, but it also has interactive flash eLearning material to educate users about the company's novel approach.
Cyber-Duck are currently launching extensive Online Marketing campaigns to promote Syntaxin on the World Wide Web. In the meantime Syntaxins CEO, Patrick Doyle mentioned: "I am delighted with the work Cyber-Duck have done for the re-launch of the Syntaxin website and brand and I feel confident that the striking new look for Syntaxin will represent us well as we progress and grow our business."
As mentioned previously Cyber-Duck produced a new and fresh brand that would fully demonstrate Syntaxin's position as a leader in the biotech industry. This included not only just re-producing their logo, but also creating a full branding solution that could be rolled out in their print material, powerpoint pitches, CDs/promotional material and of course their website. To ensure that things such as fonts, sizes, colours etc. stayed consistent throughout all brand material we also developed a detailed and in-depth branding guideline document.